Accession Number: | 0001104659-21-077205 |
Date: | 2021-06-02 |
Issuer: | NABRIVA THERAPEUTICS PLC (NBRV) |
Original Submission Date: |
CORRIGAN MARK
414 COMMERCE DR.
SUITE 120
FORT WASHINGTON, PA 19034
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SHARE OPTIONS | 1.39 | 2021-06-02 | deemed execution date | A | 10,500 (a) | 2031-06-01 | ordinary shares 10,500 | $1.39 | 10,500 | direct |
ID | footnote |
---|---|
f1 | the option was granted on june 2, 2021. |
f2 | the option will vest over a three-year period on a monthly pro rata basis beginning on june 2, 2021 and subject to the reporting person's continued service on the board of directors of the issuer. |